Connect with us during Formulation & Delivery US 2023

Our experts are attending the Formulation & Delivery US in San Diego (2-3 October 2023). Connect with our team to learn how we can help you to overcome the challenges of complex drug product development.

During the Formulation & Delivery US 2023 Conference in San Diego, you can connect with our experts and learn how our scientists provide development support for a wide range of pharmaceutical dosage forms. 

Our specialist expertise in orally inhaled and nasal drug development is integrated with formulation and testing services for both small molecules and biologics. Our teams carry out early-stage pre-formulation support, solubility screening, drug-excipient compatibility, stability testing, extractables and leachables testing and device selection support.

Conference Presentation
During the event our expert, Mark Zurbruegg, Group Leader E&L, Intertek Switzerland, will present on extractables and leachables strategies to overcome challenges posed by complex drug delivery formats such as inhaled or nasal drug products.

Regulatory driven extractables and leachables studies: Overcoming challenges for key drug delivery formats
Day 1, 02 OCTOBER 2023 | Track 4: Inhaled Therapies | 14:55

The Formulation & Delivery US 2023 event is also an opportunity to discuss with experts the latest innovations for biopharmaceutical development. For inhaled biologic development, we provide comprehensive protein characterisation services which are supported by forced degradation and stability monitoring for the protein’s structure and bioactivity throughout formulation and storage. Interaction with the delivery device and closure systems are evaluated through comprehensive extractable and leachable testing and toxicological assessments. You can find out more at our booth - reach out to our team now. 

CONFERENCE RESOURCES:  
BROCHURE: Inhaled or Nasal Biologic Drug Development 
BROCHURE: Intertek Pharmaceutical Services
BROCHURE: Stability Testing and Storage Capabilities 
BROCHURE: Intertek Inhaled Product Development Brochure

DOWNLOADS:

• Webinar | The Fundamentals of Inhaled Product Testing 
•  Article | Considerations for Nebulised Therapeutic Development  
• Webinar | Repurposing Products for Inhaled Delivery  
• White Paper | Intranasal Delivery of Biologic Therapeutics
• Webinar | Pharmaceutical Stability Studies and Outsourcing  
• White Paper | Formulation and Manufacturing of Nasal Drug Products
• Intertek Inhaled Product Development
• Intertek ICH Stability Studies and Storage 

Learn more about the Conference

With 30 years of experience in supporting our clients’ inhaled and nasal product developments, we deliver world-class support to help you meet the challenges of your demanding development programs. The Intertek Melbourn laboratory is inspected and approved by the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for GMP compliance. The Laboratory has also been inspected by the US Food and Drug Administration (FDA) against GMP as part of clients’ pre-approval inspections.